Medical Technologies
Download Our Guide
Navigating the 2024-25 Respiratory Illness Season
A Clinical Trials Guide for Diagnostic Device Original Equipment Manufacturers (OEMs).
As the autumn season approaches, so does the respiratory illness season. This period witnesses an upswing in cases of influenza and various other respiratory viruses, alongside an increase in incidents of group A streptococcal (Strep A) infections. In the realm of clinical trials, preparation for ‘the season’ is initiated in advance, enabling preparation to procure the required influenza A, B, (Flu A/B) and other respiratory virus specimens crucial for substantiating a device’s regulatory submissions.
Key Highlights
- COVID-19's Ripple Effect - Discover how the pandemic has set a trend precedent for the timeline and peak of respiratory illness seasons.
- Upcoming Season Expectations - Equip yourself with knowledge of predictive models indicating the extended season for 2024-2025.
- Developer Direction - Grasp the best practices and recommendations for in vitro diagnostics (IVD) developers.
- Regulatory Landscape - Understand the nuances of FDA engagements, off-season studies, and more.
- Partner With TE Connectivity - Learn why partnering with TE’s IVD Solutions Team could be right for you.
Download the Clinical Trials Guide for Diagnostic Device OEMs Now!
Stay a step ahead for the 2024-25 respiratory illness season. Discover insights, strategies, and recommendations from experienced industry professionals.
